一个成年移植接受者的血红球氨基酸过敏症是用手术内ECMO治疗的
Yannis Karamitas1, Alexander Vu2, Ryan Robalino2
1NYU Langone Health, New York, New York, USA yannis.karamitas@nyulangone.org.
BMJ case reports
|June 17, 2025
概括
本案例报告详细介绍了使用体外膜氧化 (ECMO) 来管理移植期间的严重过敏反应. ECMO使患者稳定,使移植成功,并突出其在关键的外科手术前事件中的救生潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 心血管外科心血管外科
背景情况:
- 接受脏移植的人面临外科手术期间的风险,包括严重的过敏反应.
- 胸球蛋白诱导疗法可以引发危及生命的过敏反应.
- 在移植期间控制过敏反应需要迅速干预和先进的支持.
研究的目的:
- 报告了第一个经过手术的体外膜氧化 (ECMO) 用于球蛋白诱导的过敏反应在移植接受者的记录.
- 突出ECMO在稳定移植期间耐性过敏反应和血液动力学崩的患者的疗效.
- 强调多学科合作和准备在管理罕见但关键的术后并发症的重要性.
主要方法:
- 一个病例报告,一名脏移植接受者在输血时经历了严重的过敏反应.
- 利用毒性ECMO提供血液动力学和呼吸支持.
- 在患者稳定后成功进行移植.
主要成果:
- 患者患上了危及生命的过敏反应,其特征是缺氧,低血压和支气管,由酶水平升高证实.
- 术内静脉ECMO成功稳定了患者的耐火性缺氧和血液动力学崩.
- 移植在第二天顺利完成,经过调整的免疫抑制疗法.
结论:
- 术内ECMO可以作为一种拯救生命的干预措施,用于治疗移植患者的严重过敏反应.
- 在外科手术期间,早期识别和及时治疗过敏反应至关重要.
- 多学科团队的准备对于复杂的移植病例的成功结果至关重要.
相关概念视频
01:26Kidney Transplant II: Surgical Procedure
78
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78
01:16Kidney Transplant III: Nursing Management
88
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
88
01:28Kidney Transplant I: Introduction
65
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
01:22Acute Kidney Injury I: Introduction
83
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
83
01:30Continuous Renal Replacement Therapy
156
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
156